LENZ Therapeutics, Inc. (LENZ)
3.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
3.21
+0.06
(+1.90%)
After-Hours: 20:00
LENZ Therapeutics Market Cap : 98.96M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 98.96M |
| October 26, 2026 | 98.81M |
| October 23, 2026 | 99.28M |
| October 22, 2026 | 102.10M |
| October 21, 2026 | 101.16M |
| October 20, 2026 | 100.22M |
| October 19, 2026 | 103.68M |
| October 16, 2026 | 102.73M |
| October 15, 2026 | 112.16M |
| October 14, 2026 | 107.76M |
| October 13, 2026 | 106.82M |
| October 12, 2026 | 113.42M |
| October 09, 2026 | 114.51M |
| October 08, 2026 | 110.90M |
| October 07, 2026 | 113.73M |
| October 06, 2026 | 119.07M |
| October 05, 2026 | 112.79M |
| October 02, 2026 | 112.47M |
| October 01, 2026 | 119.07M |
| September 30, 2026 | 120.64M |
| September 29, 2026 | 121.27M |
| September 28, 2026 | 124.41M |
| September 25, 2026 | 123.00M |
| September 24, 2026 | 116.87M |
| September 23, 2026 | 118.13M |
| Date | Value |
|---|---|
| September 22, 2026 | 129.75M |
| September 21, 2026 | 128.18M |
| September 18, 2026 | 127.87M |
| September 17, 2026 | 129.75M |
| September 16, 2026 | 130.07M |
| September 15, 2026 | 132.89M |
| September 14, 2026 | 140.43M |
| September 11, 2026 | 142.00M |
| September 10, 2026 | 148.29M |
| September 09, 2026 | 154.26M |
| September 08, 2026 | 167.45M |
| September 04, 2026 | 187.24M |
| September 03, 2026 | 183.16M |
| September 02, 2026 | 182.22M |
| September 01, 2026 | 164.31M |
| August 31, 2026 | 163.68M |
| August 28, 2026 | 160.54M |
| August 27, 2026 | 151.12M |
| August 26, 2026 | 150.17M |
| August 25, 2026 | 146.72M |
| August 24, 2026 | 144.20M |
| August 21, 2026 | 147.03M |
| August 20, 2026 | 146.40M |
| August 19, 2026 | 154.57M |
| August 18, 2026 | 149.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Impact BioMedical, Inc. | 30.33M |
| Enveric Biosciences, Inc. | 5.589M |
| Liquidia Corp. | 4.049B |
| Aquestive Therapeutics, Inc. | 510.83M |
| ANI Pharmaceuticals, Inc. | 1.635B |
Market Cap Related Metrics
| PS Ratio | 4.486 |
| PEG Ratio | -0.0067 |
| Price to Book Value | 0.4513 |
| Price | 3.15 |
| Earnings Yield | -129.6% |
| PEGY Ratio | -0.0067 |